FinArc Investments’s Johnson & Johnson JNJ Stock Holding History

FinArc Investments’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.76M	Sell	10,887 -193	-2%	-$45K	2.51%	13
2026 Q1	$2.71M	Buy	+11,080	New	+$2.58M	2.61%	13

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FinArc Investments's JNJ Position: Q2 2026 in Review

FinArc Investments reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $45K and leaving 10,887 shares worth $2.76M. The position accounts for 2.51% of the portfolio, ranked #13.

FinArc Investments first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

FinArc Investments held 10,887 shares of Johnson & Johnson worth $2.76M as of Q2 2026.
FinArc Investments sold 193 Johnson & Johnson shares in Q2 2026, an estimated $45K.
Johnson & Johnson made up 2.51% of FinArc Investments's portfolio in Q2 2026, its #13 holding.
FinArc Investments first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on FinArc Investments's 13F filing for Q2 2026, filed 13 Aug 2026.